Macrolide
Antibiotics market accounted for
US$ 39.7 billion in 2020 and is estimated to be US$ 118.1 billion by 2030 and
is anticipated to register a CAGR of 11.5%. Antibiotics originating from Saccharopolyspora
erythraea are known as macrolide antibiotics. Macrolide antibiotics have a wide
range of action against many gram-positive bacteria and are bacteriostatic in
nature. Soft tissue infections, respiratory infections, sexually transmitted
infections, and atypical mycobacterial infections are all treated with
macrolide antibiotics. Macrolide antibiotics have anti-inflammatory and
immunomodulatory properties and are used to treat a variety of ailments.
Macrolide antibiotics can be used as a first- or second-line therapy, depending
on the situation. Erythromycin is used as a second-line treatment for allergies
and is used as a first-line treatment for pertussis and other disorders.
The report " Global Macrolide antibiotics Market, By drug type
(Azithromycin, erythromycin, telithromycin, calirithromycin and fidaxomycin),
By Infection (legionella sp., mycoplasma pneumonia, peliosishepatis, bordetella
pertussis and others), By Route of administration (oral and parenteral),By
End-user, hospital, clinics, ambulatory center, research center and
others), and By Region (North America, Europe, Asia Pacific, Latin America, and
Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”
Key Highlights:
·
Oritavancin,
delbavancin, and televancin are three new Glycopepetide derivatives produced in
response to the emergence of vancomycin-resistant strains. The FDA has approved
televancin, but oritavancin and delbavancin are still in progress.
Analyst View:
The global demand for Macrolide Antibiotics is
expected to expand in the coming years, owing to the rise in antibiotic use.
The global macrolide antibiotics market is expected to develop rapidly during
the forecast period, owing to rising macrolide demand around the world. The
market is also expected to rise due to the rising prevalence of bacterial skin
infections and the growing number of dermatology clinics. Furthermore, the
macrolide drug market is being driven by a growing elderly population, an
unprecedented rate of multi-strain resistant bacterial strains, and better
benefits over traditional antibiotics.
Before purchasing this report, request a sample or make an inquiry
by clicking the following link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4689
Key Market Insights from the report:
The Global Macrolide Antibiotics market accounted
for US$ 39.7 billion in 2020 and is estimated to be US$ 118.1 billion by 2030
and is anticipated to register a CAGR of 11.5%. The Global Macrolide
Antibiotics Market is segmented based on the drug type, Infection, route of
administration, end-user and region.
·
By drug type,
the Global Macrolide antibiotics Market is segmented into Azithromycin, erythromycin, telithromycin,
calirithromycin and fidaxomycin.
·
By Infection,
the market is segmented in legionella sp., mycoplasma pneumonia,
peliosishepatis, bordetella pertussis and others.
·
By route of
administration, the Global Macrolide Antibiotics Market is segmented into Oral
and Parenteral.
·
By End-User,
the market is segmented into hospital, clinics, ambulatory center, research
center and others
·
By region, the
Global Market is segmented into North America, Europe, Asia Pacific, Latin
America, and Middle East & Africa.
Competitive Landscape:
The key players operating in the global covid-19 sample collection
kits market includes AbbVie Inc.,
Allergan, AstraZeneca, Merck & Co., Inc., GlaxoSmithKline plc., Johnson
& Johnson Services, Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Eli Lilly
And Company., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries
Ltd., Novartis AG, Boehringer Ingelheim International Gmbh, Sanofi,
Astrazeneca, Abbott, Bayer AG, Sandoz International GmbH and others
The market provides detailed information
regarding the industrial base, productivity, strengths, manufacturers, and
recent trends which will help companies enlarge the businesses and promote
financial growth. Furthermore, the report exhibits dynamic factors including
segments, sub-segments, regional marketplaces, competition, dominant key
players, and market forecasts. In addition, the market includes recent
collaborations, mergers, acquisitions, and partnerships along with regulatory
frameworks across different regions impacting the market trajectory. Recent
technological advances and innovations influencing the global market are
included in the report.
